RESEARCH TRIANGLE PARK, N.C., Oct. 11 /PRNewswire-FirstCall/ —
Talecris Biotherapeutics Holdings Corp. (Nasdaq:
TLCR) will issue its third quarter 2010 earnings release before
the market opens on October 28, 2010. Due to the pending merger
with Grifols, S.A., Talecris will not be hosting a conference call
to discuss its third quarter results.
About Talecris Biotherapeutics: Inspiration.
Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and
biotechnology company that discovers, develops and produces
critical care treatments for people with life-threatening disorders
in a variety of therapeutic areas including immunology,
pulmonology, neurology and hemostasis. For more information, please
visit:
www.talecris.com.
‘/>”/>
SOURCE
